Vimarsana
Biggest News Aggregation in the World

Rivkin Foundation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rivkin Foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rivkin Foundation Today - Breaking & Trending Today

Fall events | Federal Way Community Calendar | Federal Way Mirror - Vimarsana News

Fall events | Federal Way Community Calendar | Federal Way Mirror

Don’t miss Branch Out at the Pacific Bonsai Museum, hosted at the former Weyerhaeuser headquarters on Oct. 1 from 1 p.m. to 4 p.m.

Israeli Scientists Make New Breakthrough in Treating Ovarian Cancer - Vimarsana News

Israeli Scientists Make New Breakthrough in Treating Ovarian Cancer

Israel leads the world in cancer research.

RNA-based Nano-medicine To Treat Ovarian Cancer Reaches 80 Percent Survival Rate In Animals - Vimarsana News

RNA-based Nano-medicine To Treat Ovarian Cancer Reaches 80 Percent Survival Rate In Animals

'We proved that CKAP5, a protein responsible for cell stability, can be silenced and that this procedure destroys the entire cancer cell'

Source: i24news.tv
Mirvetuximab soravtansine shows antitumor activity in platinum resistant ovarian cancer - Vimarsana News

Mirvetuximab soravtansine shows antitumor activity in platinum resistant ovarian cancer

Mirvetuximab soravtansine demonstrated efficacy and tolerability in patients with platinum resistant ovarian cancer, according to phase 3 clinical data presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.

Source: healio.com
Mirvetuximab Soravtansine: A New Standard of Care in Ovarian Cancer? - Vimarsana News

Mirvetuximab Soravtansine: A New Standard of Care in Ovarian Cancer?

Mirvetuximab soravtansine produced responses in platinum-resistant, high-grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancers with high FRα expression.